史上首个AI设计药物：强迫症新药DSP-1181

由Exscientia与住友制药合作开发的DSP-1181，作为全球首个完全由AI设计的药物，于2020年1月在日本启动I期临床试验，旨在治疗强迫症（OCD）。

来源

• The Potential Applications of Artificial Intelligence in Drug Discovery and Development
• First Drug Created Via AI to Enter Clinical Trials, Signaling New Era for Pharma
• Sumitomo Dainippon Pharma and Exscientia Joint Development New Drug Candidate Created Using Artificial Intelligence (AI) Begins Clinical Study
• A new paradigm for drug development - PMC - NIH
• AI drug discovery: assessing the first AI-designed drug candidates for humans - CAS.org
• AI 药物发现：评估首批进入人体临床试验阶段的AI 设计候选药物 - CAS.org

打开完整版